COMPOSITION POUR ADMINISTRATION ORALE DE MAGNESIUM, EN ASSOCIATION AVEC UNE COMPOSITION DESTINEE A TRAITER LE DIABETE DE TYPE 2 OU SES COMPLICATIONS

Patent europeic · EP3007683 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3007683
Numer da la dumonda
EP14727570
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
03-06-2014
Publitgà
20-04-2016
Concedì
30-10-2019
La protecziun finescha il pli tard
02-06-2034
Proxima taxa annuala scadenta
30-06-2026
Classas IPC
A61K 33/06 (2006.01)
A61K 9/28 (2006.01)
A61K 45/06 (2006.01)
A61P 3/10 (2006.01)
Prioritad
EP 13305789 11.06.2013
Dumonda PCT
PCT/EP2014/061518 03.06.2014
Publicaziun PCT
WO2014/198591 18.12.2014
Lingua da l’annunzia
franzos
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-12-2025

    Midada

    Published in Swissreg on 22.12.2025

  2. 24-12-2024

    Midada

    Published in Swissreg on 24.12.2024

  3. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  4. 08-05-2023

    Adressa midada

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.05.2023

  5. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  6. 21-02-2020

    Represchentant inscrit

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 21.02.2020

  7. 30-10-2019

    Concedì

    Published in Swissreg on 30.10.2019

Partidas

Inventur

Joanny Menvielle-Bourg, Fabienne

06400 Cannes, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.